Anti-IGF1 Receptor antibody [EPR23027-80]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
5
(1 Review)
|
(5 Publications)
Knockout Tested Rabbit Recombinant Monoclonal IGF1 Receptor antibody. Suitable for IP, Flow Cyt, WB, ICC/IF and reacts with Human samples. Cited in 5 publications.
View Alternative Names
CD221, Insulin-like growth factor 1 receptor, Insulin-like growth factor I receptor, IGF-I receptor, IGF1R
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-IGF1 Receptor antibody [EPR23027-80] (AB263907)
Immunofluorescent analysis of 100% Methanol-fixed MCF7 (human breast adenocarcinoma epithelial cell) cells labelling IGF1 Receptor with ab263907 at 1/100 dilution, followed by ab150077 AlexaFluor®488 Goat anti-Rabbit secondary antibody at 1/1000 dilution (Green). Confocal image showing membranous staining in MCF7 cell line. ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at1/200 dilution (Red). The Nuclear counterstain was DAPI (Blue).
Secondary antibody only control : Secondary antibody is ab150077 AlexaFluor®488 Goat anti-Rabbit secondary at 1/1000 dilution.
- Flow Cyt
Unknown
Flow Cytometry - Anti-IGF1 Receptor antibody [EPR23027-80] (AB263907)
Flow cytometric analysis MCF7 (human breast adenocarcinoma epithelial cell) cells labelling IGF1 Receptor with ab263907 at 1/500 dilution (Red) compared with a Rabbit monoclonal IgG (ab172730) / Black isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody.
Gated on viable cells.
- IP
Unknown
Immunoprecipitation - Anti-IGF1 Receptor antibody [EPR23027-80] (AB263907)
IGF1 Receptor was immunoprecipitated from 0.35 mg MCF7 (human breast adenocarcinoma epithelial cell) whole cell lysate with ab263907 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab263907 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : MCF7 (human breast adenocarcinoma epithelial cell) whole cell lysate 10ug
Lane 2 : ab263907 IP in MCF7 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab263907 in MCF7 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 min.
All lanes:
Immunoprecipitation - Anti-IGF1 Receptor antibody [EPR23027-80] (ab263907)
Predicted band size: 154 kDa
Observed band size: 130 kDa
false
- WB
Lab
Western blot - Anti-IGF1 Receptor antibody [EPR23027-80] (AB263907)
Lanes 1- 2 : Merged signal (red and green). Green - ab263907 observed at 100 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab263907 was shown to react with IGF1 Receptor in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab264801 (knockout cell lysate ab256951) was used. Wild-type HeLa and IGF1R knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab263907 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-IGF1 Receptor antibody [EPR23027-80] (ab263907) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
IGF1R knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human IGF1R (IGF1 Receptor) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-igf1r-igf1-receptor-knockout-hela-cell-line-ab264801'>ab264801</a>)
Predicted band size: 154 kDa
Observed band size: 100 kDa
false
- WB
Lab
Western blot - Anti-IGF1 Receptor antibody [EPR23027-80] (AB263907)
False colour image of Western blot : Anti-IGF1 Receptor antibody [EPR23027-80] staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab263907 was shown to bind specifically to IGF1 Receptor. A band was observed at 105-125 kDa (alpha chain) in wild-type MCF7 cell lysates with no signal observed at this size in IGF1R knockout cell line. To generate this image, wild-type and IGF1R knockout MCF7 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-IGF1 Receptor antibody [EPR23027-80] (ab263907) at 1/1000 dilution
Lane 1:
Wild-type MCF7 cell lysate at 20 µg
Lane 2:
IGF1R knockout MCF7 cell lysate at 20 µg
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
HDLM-2 cell lysate at 20 µg
Observed band size: 105-125 kDa
false
- WB
Unknown
Western blot - Anti-IGF1 Receptor antibody [EPR23027-80] (AB263907)
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : 10 seconds.
The expression profile & molecular weight observed is consistent with what has been described in the literature (PMID : 21807868, 28591735).
Note : the bands larger than 200kDa are Pro-IGF1R.
Low expression cell line : MDA-MB-231 (PMID : 28591735).
All lanes:
Western blot - Anti-IGF1 Receptor antibody [EPR23027-80] (ab263907) at 1/1000 dilution
Lane 1:
A431 (human epidermoid carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
MDA-MB-231 (human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 154 kDa
Observed band size: 130 kDa,200 kDa
false
Related conjugates and formulations (1)
-
Anti-IGF1 Receptor antibody [EPR23027-80] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IGF1R contributes to several cellular processes including cell proliferation differentiation and survival. This receptor forms a complex upon ligand binding and undergoes autophosphorylation to activate intracellular signaling cascades. IGF1R activation recruits and phosphorylates insulin receptor substrates enabling the downstream signaling pathways that promote cell growth and survival. Its function in cellular responses makes it a focal point in understanding cell biology.
Pathways
IGF1R holds a central position in the PI3K/AKT and MAPK signaling cascades. These pathways play significant roles in cellular growth proliferation and survival. IGF1R phosphorylates various downstream effectors such as IRS-1 and Shc linking it to the activation of AKT and ERK respectively. Therefore it shares pathways with related proteins like the insulin receptor highlighting its importance in mediating similar biological responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e2406965 PubMed39698844
2024
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 19:e0313867 PubMed39570927
2024
Applications
Unspecified application
Species
Unspecified reactive species
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 40:2425318 PubMed39505692
2024
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:6293-6308 PubMed35212614
2022
Applications
WB
Species
Human
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 141:415-426 PubMed33116033
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com